bpc 157 not approved for human use regulatory status ππ»ββοΈ Is the lack of data in BPC-157 a red flag? β’ If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury fda warning bpc-157 unapproved new
Description
Some prefer tapering (reducing dose 50% for 2 weeks then stopping) preventing sudden withdrawal of support

I'm like, Come on, let's go, man

doi: 10.1152/physrev.00003.2008
Day 6 had about a 5/10 headache in PM

[DOI] [PubMed] [Google Scholar] 43.Ranquet C., Ollagnier-de-Choudens S., Loiseau L., Barras F., Fontecave M